Yang Hui, Chen Weida, Jiang Guangyu, Yang Jun, Wang Weifeng, Li Hongbin
Department of Neurology, The First Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang 154001, P.R. China.
Department of Cardiology, The First Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang 154001, P.R. China.
Oncol Lett. 2020 Aug;20(2):1846-1854. doi: 10.3892/ol.2020.11716. Epub 2020 Jun 9.
Long non-coding RNAs (lncRNA) are a type of ncRNA with a length ranging from 200-1,000 nucleotides. Previous studies have confirmed that the lncRNA Ewing sarcoma associated transcript 1 (EWSAT1) exerts regulatory roles in cancer development and progression. However, its clinical significance in glioma remains unknown. In the present study, RNA-sequencing data from the Gene Expression Omnibus database and The Cancer Genome Atlas was explored to investigate the association between EWSAT1 expression and prognosis in patients with glioma. Increased EWSAT1 was associated with the presence of necrosis on magnetic resonance imaging scans in patients with glioma. Furthermore, knockdown of EWSAT1 was indicated to suppress the proliferative and invasive abilities of glioblastoma cell lines using Cell Counting Kit-8 and Transwell assays. Additionally, microRNA (miR)-152-3p was identified as a potential target of EWSAT1. The present study demonstrated that EWSAT1 interacted directly with miR-152-3p, and rescue experiments confirmed that EWSAT1 participated in glioma development by suppressing miR-152-3p. These results indicated that EWSAT1 is involved in the occurrence and progression of glioma, and may serve as a novel target and potential prognostic biomarker of glioma treatment.
长链非编码RNA(lncRNA)是一类长度在200至1000个核苷酸之间的非编码RNA。先前的研究证实,尤因肉瘤相关转录本1(EWSAT1)在癌症发展和进程中发挥调控作用。然而,其在胶质瘤中的临床意义仍不明确。在本研究中,对来自基因表达综合数据库和癌症基因组图谱的RNA测序数据进行了探索,以研究EWSAT1表达与胶质瘤患者预后之间的关联。EWSAT1表达增加与胶质瘤患者磁共振成像扫描中坏死的存在相关。此外,使用细胞计数试剂盒8和Transwell实验表明,敲低EWSAT1可抑制胶质母细胞瘤细胞系的增殖和侵袭能力。此外,微小RNA(miR)-152-3p被确定为EWSAT1的潜在靶点。本研究表明,EWSAT1直接与miR-152-3p相互作用,挽救实验证实EWSAT1通过抑制miR-152-3p参与胶质瘤的发展。这些结果表明,EWSAT1参与胶质瘤的发生和发展,并可能作为胶质瘤治疗的新靶点和潜在预后生物标志物。